Self-Management for Persistent Subacromial Pain
- Conditions
- Shoulder Pain Chronic
- Registration Number
- NCT04190836
- Lead Sponsor
- Oslo Metropolitan University
- Brief Summary
Physiotherapy-led exercises is the first line treatment for patients with subacromial pain. However, current evidence report that most treatment programmes only show a short-term benefit. There seem to be a potential for enhancing the effectiveness of exercise interventions by improving adherence to self-managed exercises, but there is lack of knowledge about adherence to exercise programmes in shoulder pain. Before conducting a planned randomised controlled trial on the clinical effectiveness of an intervention focusing on adherence to a self-managed exercise strategy (the Ad-Shoulder intervention), it is necessary to run a feasibility study in order to establish whether such a resource-demanding trial is worthwhile. Feasibility studies are designed to answer the key question "Can it work?" The main objectives of the present study was to assess the feasibility in terms of recruitment capability, data collection procedures and acceptability of the Ad-Shoulder intervention in patients with subacromial pain receiving treatment in primary or secondary health care.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 11
- Pain located to the upper arm
- Had previously received conservative treatment due to subacromial pain
- Still seek primary or secondary care during the past 6 months
- Frozen shoulder diagnosis (<50% external rotation compared to contralateral side)
- Patients who have received surgical treatment due to shoulder problems
- Pregnant patients
- Patients with insufficient Norwegian language skills
- Serious psychiatric disorder
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method Follow-up rate 3 months Determine the follow-up rate - measured by the percentage of participants who were followed up successfully until the three months follow-up
Adherence 3 months Determine whether the patients adhere with the self-managed exercises - measured by self-reported exercise log book
Recruitment rate 3 months How many people that were eligible and how many people that were recruited per week
Actigraph assessment of physical activity 3 months Feasibility of Actigraph assessment of physical activity - measured by percentage of participants with valid data at Week 0, Week 6 and 3 months
Fidelity 3 months Determine whether the therapists delivered the intervention as planned - measured by assessing the therapists' log book
Adverse events 3 months Determine number and nature of adverse events via self-report questionnaire
- Secondary Outcome Measures
Name Time Method Physical activity (self-reported) 3 months Physical activity will be assessed by the 3 questions from the Nord-Trondelag Health Study (HUNT) regarding frequency, intensity and duration.
Shoulder pain and disability index (SPADI) 3 months SPADI is a self-reported questionnaire for patients with shoulder pain. The questionnaire consists of 13 questions divided into two domains: pain (five items) and function (eight items) and scored on a numerical scale 0 (best) to 10 (worst) with a score range from 0 to 100 points
Numeric Pain Rating Scale (NPRS) 3 months Pain intensity during the last week was measured using the NPRS (ranging from 0 = no pain, 10 = the most intense pain imaginable). Repeated measures: During a one week pre-treatment phase (A), 3 times. During the 12 week treatment phase (B): collected twice every week. During a one week post-treatment phase (A): 3 times
Kinesiophobia 3 months Kinesiophobia will be assessed using one question: "How much 'fear' do you have that these complaints would be increased by physical activity? (scores range from 0 = no fear, to 10 = very much fear).
EQ-5D-5L 3 months Generic health-related quality of life will be assessed by the EQ-5D. It evaluates 5 dimensions: mobility, self-care, activities of daily living, pain, and anxiety and/or depression. For each dimension the patient describes three possible levels of problems (none, mild-to-moderate, and severe).
Bergen Insomnia Scale 3 months Pain-interference with sleep will be assessed by the Bergen Insomnia Scale, which consists of six items. Scoring 3 or above on at least one of the first four items and scoring 3 or above on at least one of the last two items indicate the presence of insomnia.
Working Ability Index 3 months Work ability will be measured on a 11-point scale (0 = Can not work at all, 10 = working ability is best right now)
Patient Specific Function Scale (PSFS) 3 months PSFS is a patient specific outcome measure where the patient is asked to name three activities which the patient find challenging or are not able to do because of their shoulder pain. Patients rate their ability to complete the activities on a 11-point scale at a level experienced prior to injury or change in functional status. "0" represents "unable to perform" and "10" represents "able to perform at prior level".
Pain self-efficacy 2-item short form (PSEQ-2 item) 3 months Measured using a 2-item questionnaire by asking the patients' how confident they are doing some form of work and to live a normal lifestyle at present, despite the pain (ranging from 0 = not at all confident, 6 = completely confident). Repeated measures: During a one week pre-treatment phase (A), 3 times. During the 12 week treatment phase (B): collected twice every week. During a one week post-treatment phase (A): 3 times
Self-efficacy 3 months Measured using one modified question from the Musculoskeletal Health Questionnaire: "How confident have you felt about managing your shoulder pain by yourself (responses were not at all confident, slightly, moderately, very and extremely)? Repeated measures: During a one week pre-treatment phase (A), 3 times. During the 12 week treatment phase (B): collected twice every week. During a one week post-treatment phase (A): 3 times
Global Perceived Effect scale (GPE) 3 months The patient rated perception of change at the follow-ups will be assessed on a Global Perceived Effect scale (GPE) at follow-up (52). The response alternatives were: 1 = "completely recovered", 2 = "much improved", 3 = "slightly improved", 4 = "no change", 5 = "slightly worse", 6 = "much worse", and 7 = "worse than ever".
Physical activity (accelerometer) 3 months To objectively measure physical activity an accelerometer (AX3, 3-axis Logging Accelerometer) was used. This accelerometer provides information about movement and will enable us to objectively measure the amount of general physical activity (minutes of moderate activity). The patients will be measured for three consecutive days at baseline, at 6 weeks and at 3 months to assess changes between the three time points (Week 0, Week 6 and 3 months.
Trial Locations
- Locations (2)
Diakonhjemmet Hospital
🇳🇴Oslo, Norway
Oslo Metropolitan University
🇳🇴Oslo, Norway
Diakonhjemmet Hospital🇳🇴Oslo, Norway